Ticker: CBPO, Company: China Biologic Products, Inc., Type: 8-K, Date: 2015-03-04
Original SEC Filing: Click here

---

Webplus: CBPO/20150304/8-K/2_EX-10.1/000.htm SEC Original: v403468_ex10-1.htm
CHINA BIOLOGIC PRODUCTS, INC. DIRECTOR AGREEMENT Agreement Company Mr. Min Fang Director THIS AGREEMENT (The “ BACKGROUND The Board of Directors of the Company desires to appoint the Director to fill an existing vacancy due to resignation of Mr. Dai Feng and to have the Director perform the duties of a director and the Director desires to be so appointed

---

---

Webplus: CBPO/20150304/8-K/3_EX-99.1/000.htm SEC Original: v403468_ex99-1.htm
FOR RELEASE March 4, 2015 China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 4Q14 Total Sales Up 36.2% to 58.0 Million / FY14 Total Sales Up 19.6% to $243.3 Million — — — 4Q14 Operating Margin Up 470 Basis Points to 34.0% / FY14 Operating Margin Up 300 Basis Points to 45.7% — — 4Q14

---

---

Webplus: CBPO/20150304/8-K/1/000.htm SEC Original: v403468_8k.htm

---

Company Information:

Ticker: CBPO, Company: China Biologic Products, Inc., Type: 8-K, Date: 2015-03-04CIK: 0001369868, Location: F4, SIC: 2836, SIC Desc: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)
Business Phone & Address:
18TH FL, JIALONG INTERNATIONALBUILDING
BEIJING 100125